retatrutide phase 2 trial type 2 diabetes weight loss 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending Retatrutide improves blood sugar and

In some cases, these symptoms progress to gastroparesis or intestinal blockage, requiring extensive medical treatment or surgery

Clin Nutr (2017) 36(6):17079.10.1016/j.clnu.2016.09.028 187 LiuRHongJXuXFengQZhangDGuYet alGut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

Fermentation of Fiber Beneficial gut bacteria break down dietary fiber into short-chain fatty acids (SCFAs), such as butyrate and propionate

Speedy delivery

Common Reasons for Weight Loss Plateaus on GLP-1 Drugs 1

When discussed in the media, it has been nicknamed Triple G. By working on three hormones, retatrutide has been demonstrated in clinical trials to help reduce appetite, control blood sugar, and promote fat loss